NRX Therapeutics Inc Share Price Today: Live Updates & Key Insights
NRX Therapeutics Inc share price today is $1.81, up 0.54%. The stock opened at $1.815 against the previous close of $1.84, with an intraday high of $1.905 and low of $1.79.
NRX Therapeutics Inc Share Price Chart
NRX Therapeutics Inc
NRX Therapeutics Inc Share Price Performance
NRX Therapeutics Inc Institutional Holdings
NRX Therapeutics Inc Market Status
NRX Therapeutics Inc Fundamentals
Market Cap 58.96 M
PB Ratio 2.9042
PE Ratio 0.0
Enterprise Value 61.39 M
Total Assets 3.65 M
Volume 807933
NRX Therapeutics Inc Company Financials
About NRX Therapeutics Inc & investment objective
Company Information NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression. The company has a license agreement with Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd.; Apkarian Technologies; development and license agreement with Glytech, LLC; and Sarah Herzog Memorial Hospital; and has as a partnership with neurocare Group AG to create a nationwide network of clinics to offer integrated neuroplastic care for the treatment of Depression, PTSD, and other serious mental health disorders. NRx Pharmaceuticals, Inc. was founded in 2015 and is based in Wilmington, Delaware.
Organisation Biotechnology
Employees 0
Industry Biotechnology
CEO Dr. Jonathan C. Javitt M.D., M.P.H.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
NRX Therapeutics Inc FAQs
What is the share price of NRX Therapeutics Inc today?
The current share price of NRX Therapeutics Inc is $1.81.
Can I buy NRX Therapeutics Inc shares in India?
Yes, Indian investors can buy NRX Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy NRX Therapeutics Inc shares in India?
You can easily invest in NRX Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy NRX Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of NRX Therapeutics Inc.
Can I buy fractional shares of NRX Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of NRX Therapeutics Inc?
NRX Therapeutics Inc has a market cap of $58.96 M.
In which sector does NRX Therapeutics Inc belong?
NRX Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in NRX Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of NRX Therapeutics Inc?
The PE ratio of NRX Therapeutics Inc is N/A and the PB ratio is 2.90.